Wednesday, 24 August 2016

AstraZeneca to sell antibiotics business to Pfizer

LONDON (Reuters) - Pharmaceutical company AstraZeneca said it had agreed to sell its small molecule antibiotics business to Pfizer in a deal that could reach more than $1.5 billion.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)